JONATHAN CALKWOOD
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology GOLDEN VALLEY, MN NPI 1194765388
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology MN TG THERAPEUTICS, INC. All categories
General Payments — all program years on this page
$666,648.77
- Category: General Payments
- Program years: PY2018–2024
- Record count: 605
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $41,929.63 across 36 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,099.00 | 11 |
| Travel and Lodging | $1,811.33 | 6 |
| Food and Beverage | $1,019.30 | 19 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| TG THERAPEUTICS, INC. | $29,295.99 | 15 |
| Genentech USA, Inc. | $10,772.31 | 8 |
| Biogen, Inc. | $1,614.00 | 1 |
| CYCLE PHARMACEUTICALS INC | $45.47 | 1 |
| Vanda Pharmaceuticals Inc. | $27.48 | 2 |
| UCB, Inc. | $26.59 | 1 |
| Amgen Inc. | $22.91 | 1 |
| Lundbeck LLC | $21.50 | 1 |
| Pharming Healthcare, Inc. | $19.01 | 1 |
| Oyster Point Pharma, Inc. | $18.87 | 1 |
| Mylan Specialty L.P. | $17.79 | 1 |
| Celgene Corporation | $17.32 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.77 | 1 |
| Alnylam Pharmaceuticals Inc. | $13.62 | 1 |
By program year
Records — PY2024 (36)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.